Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Rubicon Research Acquisition Worth ₹175.9 Cr

Rubicon Research Limited is acquiring an 85% stake in Arinna Lifesciences Limited for approximately ₹175.92 Crore. Arinna is a specialist in the CNS therapeutic segment with a dedicated field force. This acquisition allows Rubicon to leverage its IP and chronic products portfolio while gaining access to Arinna’s established Indian sales and distribution network.

Key figures
Value₹175.9 Cr
Execution periodOne month
Source

NSE filing, NSE: RUBICON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rubicon Research Ltd: key numbers

Share price
₹1,564.00
Market cap
₹25,889 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹246.7 Cr
P/E (TTM)
89.8×Sector 46.1×
Promoter holding
51.25%-8.51% QoQ
FII holding
9.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rubicon Research Ltd

All →

Other acquisition announcements

All →